Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

Not available.

Saved in:
Bibliographic Details
Main Authors: Ali Alsugair, Saubia Fathima, Fnu Aperna, Naseema Gangat, Ayalew Tefferi
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-01-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11914
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590372925079552
author Ali Alsugair
Saubia Fathima
Fnu Aperna
Naseema Gangat
Ayalew Tefferi
author_facet Ali Alsugair
Saubia Fathima
Fnu Aperna
Naseema Gangat
Ayalew Tefferi
author_sort Ali Alsugair
collection DOAJ
description Not available.
format Article
id doaj-art-0df56852e35d429f840f966f9d813769
institution Kabale University
issn 0390-6078
1592-8721
language English
publishDate 2025-01-01
publisher Ferrata Storti Foundation
record_format Article
series Haematologica
spelling doaj-art-0df56852e35d429f840f966f9d8137692025-01-23T19:44:14ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.287032Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsAli Alsugair0Saubia Fathima1Fnu Aperna2Naseema Gangat3Ayalew Tefferi4Division of Hematology, Mayo Clinic, Rochester, MinnesotaDivision of Hematology, Mayo Clinic, Rochester, MinnesotaDivision of Hematology, Mayo Clinic, Rochester, MinnesotaDivision of Hematology, Mayo Clinic, Rochester, MinnesotaDivision of Hematology, Mayo Clinic, Rochester, Minnesota Not available. https://haematologica.org/article/view/11914
spellingShingle Ali Alsugair
Saubia Fathima
Fnu Aperna
Naseema Gangat
Ayalew Tefferi
Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Haematologica
title Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
title_full Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
title_fullStr Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
title_full_unstemmed Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
title_short Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
title_sort sodium glucose co transporter 2 inhibitor treatment associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic myeloproliferative neoplasms
url https://haematologica.org/article/view/11914
work_keys_str_mv AT alialsugair sodiumglucosecotransporter2inhibitortreatmentassociatedchangesinhemoglobinlevelinanemicpatientswithmyelodysplasticsyndromesormyelodysplasticmyeloproliferativeneoplasms
AT saubiafathima sodiumglucosecotransporter2inhibitortreatmentassociatedchangesinhemoglobinlevelinanemicpatientswithmyelodysplasticsyndromesormyelodysplasticmyeloproliferativeneoplasms
AT fnuaperna sodiumglucosecotransporter2inhibitortreatmentassociatedchangesinhemoglobinlevelinanemicpatientswithmyelodysplasticsyndromesormyelodysplasticmyeloproliferativeneoplasms
AT naseemagangat sodiumglucosecotransporter2inhibitortreatmentassociatedchangesinhemoglobinlevelinanemicpatientswithmyelodysplasticsyndromesormyelodysplasticmyeloproliferativeneoplasms
AT ayalewtefferi sodiumglucosecotransporter2inhibitortreatmentassociatedchangesinhemoglobinlevelinanemicpatientswithmyelodysplasticsyndromesormyelodysplasticmyeloproliferativeneoplasms